Neurotransmitters improve radiation and anticancer drugs
Share this article
Researchers from Ohio State University discovered that neurotransmitters might aid in the effectiveness of anticancer drugs and radiation therapy. Tests were conducted on models of human breast and prostate cancers as they were injected with the neurotransmitter dopamine. The results showed improved blood flow and oxygen levels in the tumors; these improvements typically indicate an increase in the impact that the chemo and radiation therapies have on the tumor. The study also noted that dopamine improved normal blood-vessel structures. The lack of dopamine inside tumor blood-vessels often inhibits the effectivness of cancer treatments. By improving the structures within the tumors, the oxygen and blood flow would increase, thereby allowing treatments to effectively reach the disease within the body.